Three bills on stem-cell research, one of which would fundamentally shift federal science policy, passed the Senate on Tuesday afternoon after two of days of extensive, exhaustive, and contentious debate. The landmark bill — which passed 63 to 37, and which President Bush has vowed to veto — would relax the federal government’s tight limits on which embryonic-stem-cell lines are eligible for federally subsidized research.
Office of Strategic Communication